The recently updated BHIVA guidelines note
that it may now be preferable to aim for viral load below 50 copies after 24
weeks of treatment in order to ensure the durability of anti-retroviral
response. Why have the goalposts moved again, and what does this mean for
clinical practice? US clinician William O'Brien reviews recent data in a useful
overview for the Clinical Care Options for HIV On-line Journal which can be read
at
face=Arial>http://207.226.163.175/hiv/updates/sept98/